Sponsor or institution
Clinical trials and research at Traverse Biotech Ii INC
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $697,613 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
uPAR-targeting antibody-drug conjugate for pancreatic cancer
A first-in-class antibody-drug conjugate that targets uPAR on pancreatic cancer cells and surrounding support cells is being developed as a potential new therapy for pancreatic cancer.
-
A New Oral Medicine for Visceral Leishmaniasis
This project is developing a new oral medicine called HPX-612 to help people with visceral leishmaniasis, a parasitic disease.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.